Indigo Diabetes: Funding, Investors & Team (Sep 2026)
Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology that revolutionized the Internet during the last decades and now aims at transforming diabetes management.
Indigo Diabetes has raised $38.0M across 1 funding round on record, the most recent an undisclosed round of $38.0M announced in Jul 2020.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Indigo Diabetes Company Profile and Key Stats
Latest funding round on record: Jul 2020.
Indigo Diabetes Funding Rounds
Indigo Diabetes Founders and Leadership Team
Contact details for the Indigo Diabetes team: 1 of 1 has an email address on file.
Start 14-day free trial →Indigo Diabetes Funding Compared to Other Health Care Startups
Indigo Diabetes' latest round of $38.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Indigo Diabetes in Health Care and Zwijnaarde
Companies Similar to Indigo Diabetes
ReVision Implant is a healthtech company that offers high resolution neurostimulator implant for restoring…
Maurice & Nora is a care-tech company that offers support for seniors and families.
Salvus Health is a digital health firm located in Antwerp, Belgium, dedicated to enabling individuals to take…
miDiagnostics is developing a new generation of disposable tests that require only drops of blood and allow…
PanTera specializes in mass producing actinium-225, a radioisotope with great potential for targeted cancer…
Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring…
Watcherr provides a software-as-a-service platform to clients, enabling them to gather a wide range of data…
Improved Parkinson's disease care will be possible thanks to unobtrusive sensors and AI.
Rejuvenate Biomed is a biomedical company researching the biology of aging & applying this knowledge to…
https://metriport.com
InstaAstro offers individual Astrology consultations, along with Daily Activity Tracks & Content, to assist…
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Indigo Diabetes Funding FAQs
What does Indigo Diabetes do?
Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology that revolutionized the Internet during the last decades and now aims at transforming diabetes management.
How much funding has Indigo Diabetes raised?
Indigo Diabetes has raised $38.0M across 1 round on record. The most recent is an undisclosed round of $38.0M announced in Jul 2020.
When did Indigo Diabetes last raise funding?
Indigo Diabetes' most recent funding round on record is an undisclosed round of $38.0M, announced in Jul 2020.
Who is the CEO of Indigo Diabetes?
Danae Delbeke is listed as CEO at Indigo Diabetes.
Where is Indigo Diabetes headquartered?
Indigo Diabetes is based in Zwijnaarde, Oost-Vlaanderen, Belgium.
How many employees does Indigo Diabetes have?
Indigo Diabetes is in the 11-50 employee band.
How does Indigo Diabetes' funding compare to other Health Care startups?
Indigo Diabetes' latest round of $38.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Indigo Diabetes Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Indigo Diabetes is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.